ABVC Biopharma Inc (ABVC) — Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

ABVC Biopharma Inc (ABVC) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($171.72K) in capital expenditures ($3.00). See ABVC Biopharma Inc (ABVC) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$171.72K
USD

Capital Expenditures

$3.00
USD

Data as of

Sep 2024
Most recent filing

ABVC Biopharma Inc Capital Reinvestment Ratio (2014–2014)

This chart tracks ABVC Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Check ABVC Biopharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for ABVC Biopharma Inc (2014–2014)

Year-by-year Capital Reinvestment Ratio for ABVC Biopharma Inc from 2014 to 2014. For live market cap and broader valuation context, see ABVC Biopharma Inc stock valuation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2014 16.73x $1.17K $19.55K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow